Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

EN.7 (PORTEC-3) -- A Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma -- was centrally activated September 22, 2008.
http://www.ctg.queensu.ca/trials/gynecologic/en7/en7.html